ABSTRACT
Ink4a/Arf
-/-mNSCs and such cells were highly proliferative, selfrenewing, relatively refractory to differentiation and induced both low and high grade glioma formation in vivo. In contrast to p53 -/-Pten -/-mNSCs, however, Pten INK4A deletion (31%), and Pten mutation (25%). TP53 mutations are also frequently found in primary GBM and even more frequently in low-grade gliomas that progress to secondary GBMs (2) . These glioma-related genetic alterations deregulate growth factor receptor signaling (EGFR, PDGFR, PTEN) disrupting both the cell cycle and normal regulation of apoptosis (INK4A, CDK4, RB, TP53) (3).
The role of several key genes within the RB, p53 and PI3K pathways to gliomagenesis has been investigated using various genetic mouse models. Mice lacking Pten exhibited enlarged, histoarchitecturally abnormal brains resulting from increased cell proliferation, cell size, and reduced cell death in the Pten -/-stem/progenitor cell compartment (4, 5, 6) .
For example, the combination of Ink4a/Arf ablation and expression of constitutive active EGFR in mature astrocytes resulted in the formation of glioma-like lesions following intracranial transplantation in mice (7). Trp53 and Nf1 double mutant mice generated gliomas of various stages ranging from low-grade astrocytoma to GBM (8) . Mouse strains with germline or somatic heterozygous mutations of the Trp53, Nf1, and Pten developed high-grade astrocytomas (9, 10, 11) . Despite these important studies, the Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
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The cancer stem cell hypothesis posits that tumorigenic potential is largely restricted to a subset of self-renewing tumor cells with stem cell-like properties designated as tumor stem cells (TSCs) or tumor-initiating cells (TICs) (12, 13, 14, 15) . The relatively recent identification of neural stem/progenitor cells (NSCs) within the brains of adult mammals presents an attractive theoretical and experimental target cells for acquisition of gliomacausing mutations. Consistent with such a possibility, investigation of tumor development in mouse models suggests that the tumors often arise in the subventricular zone (SVZ) where adult NSC reside (9, 10, 11, 16 
Intracranial mNSCs and GSCs Injection into SCID Mice
An intracranial orthotopic model was utilized for evaluation of mNSCs and GSCs tumorigenicity according to an approved animal study proposal by NIH-ACUC. mNSCs and GSCs were resuspended in 2 l of HBSS and injected stereotactically into the striatum of female SCID mice (6-8 week age) using a stereotactic device (coordinates, 2 mm anterior, 2 mm lateral, 2.5 mm depth from the dura). Following injection, animals were followed up daily for the development of neurological deficits.
Statistical Analysis
Student's t test was used for data analysis and a p value 0.05 was considered significant.
All values are shown as mean ± standard deviation (SD). Kaplan-Meier survival analysis was performed in Prism 4.0 software. 1C) and self-renewal capability ( Fig. 1D ; Supplementary Fig.S1B ). By contrast, the mNSCs further highlights the necessity of inactivating both rather than any one of these pathways for glioma formation.
Histologic Grade Influences Heterogeneous GSC Behavior in vitro
We next sought to determine the tumor forming capacity of GSCs derived from the GSCs whereas c-myc total protein levels became similar in all cell types following treatment with ALLN ( Fig. 4C and supplementary Fig. 3C ). Nevertheless, despite the significant difference in c-Myc protein expression and activity between Pten (Fig. 4 and Supplementary   Fig. S3 ). These data led us to further investigate genes involved in c-Myc regulation.
Fbxw7 has been shown to interact with c-Myc and mediate its ubiquitination in a Thr 58 -phosphorylation-dependent manner. Fbxw7 is a p53-dependent tumor suppressor and its activation by p53 leads to ubiquitination-mediated suppression of several oncoproteins (24, 25, 26 (Fig. 5C and 5D ). We analyzed several substrates of Fbxw7 and found that c-Jun and Aurora A are increased in GSCs although Cyclin E was not ( Supplementary Fig.S4 ). These data suggest that Fbxw7 suppresses c-Myc in Pten (Fig. 6D and 6E and 6F and 6G). These data suggest that p53 regulates c-Myc protein levels through Fbxw7 and wildtype p53 function needs to be deregulated to allow accumulation of c-Myc which is necessary for gliomagenesis.
P53-Fbxw7 pathway regulates c-Myc induced apoptosis and gliomagenesis
It has been previously demonstrated that ectopic expression of c-Myc induces apoptosis in fibroblasts in the absence of growth factors (28) , in MEFs (29) and in U87MG glioma cell lines following GSK inhibition (30) . We, therefore, hypothesized that elevated c- Fig. 7C and 7D ). These data suggest that elevated c-Myc fails to induce p53-dependent apoptosis in GSCs by inactivation of the p53-Fbxw7 pathway. Figure 7E , mice inoculated with Fbxw7 overexpressing T3 GSCs lived significantly longer than control T3 GSC inoculated animals (Median survival is 39 days for Fbxw7 and 23 days for control) (Fig. 7E ). These data demonstrate that the p53-Fbxw7 pathway is a key regulatory mechanism for controlling c-Myc induced apoptosis and gliomagenesis. (Fig. 6 and 7) . 
Myc induces p53-dependent apoptosis in
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